SCHEMBL16626490

SCHEMBL16626490

CNCc1cn(S(=O)(=O)c2cccc(OC)c2)c2cc(Nc3ccc(C(F)(F)F)cc3Cl)ccc12

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.42
FBP1 P09467 6/20 0.40
GAK O14976 1/20 0.40
SLC20A2 Q08357 1/20 0.39
SLC20A1 Q8WUM9 1/20 0.39
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
RORC P51449 3/20 0.37
RORA P35398 1/20 0.37
NR1H2 P55055 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
ELOVL6 Q9H5J4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16619220 0.99 HTR6 (0.41) HTR6FBP1GAKSLC20A2SLC20A1
SCHEMBL16626755 0.93 FBP1 (0.41) HTR6FBP1PPARGPPARDPPARA
Hydrochloric Acid SCHEMBL16619509 0.92 FBP1 (0.41) HTR6FBP1PPARGPPARDPPARA
SCHEMBL16626500 0.92 RORC (0.40) HTR6SLC20A2SLC20A1RORCCYP3A4
SCHEMBL17971558 0.92 HTR6 (0.46) HTR6FBP1
Hydrochloric Acid SCHEMBL16618896 0.91 RORC (0.40) HTR6SLC20A2SLC20A1RORCCYP3A4
SCHEMBL17971563 0.91 FBP1 (0.47) HTR6FBP1PPARGPPARDPPARA
SCHEMBL16626492 0.91 FBP1 (0.47) HTR6FBP1PPARGPPARDPPARA
SCHEMBL16626501 0.90 HTR6 (0.43) HTR6PPARGPPARDPPARARORC
Hydrochloric Acid SCHEMBL16618843 0.90 FBP1 (0.47) HTR6FBP1PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI HTR6 166/4885FBP1 74/4885GAK 1602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.